Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Vascular Malformations 1 Skin Diseases, Vascular 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Oligodendroglioma 1 Neurofibromatoses 1 Neurocytoma 1 Neoplasms, Neuroepithelial 1 NF1 1 Melanoma 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Glioma 1 Ganglioneuroma 1 Ganglioglioma 1 Central Nervous System Neoplasms 1 Astrocytoma 1 Arteriovenous Malformations 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NF1 × mirdametinib × Clear all

NCT06159166 2026-04-13

Mirda

Johns Hopkins University

Phase 1/2 Recruiting

CNSDermatologic

NF1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡